Kraig Biocraft Laboratories (KBLB) Liabilities and Shareholders Equity (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $2.6 million in Q4 2025.

• For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 70.43% year-over-year to $2.6 million; the trailing twelve-month figure through Dec 2025 stood at $7.8 million (down 8.15% YoY), and the FY2025 full-year result was $2.6 million, up 70.43% from the prior year.
• Liabilities and Shareholders Equity improved to $2.6 million in Q4 2025, from $2.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.4 million in Q2 2022 to a low of $1.3 million in Q1 2025.
• A 5-year average of $3.1 million and a median of $3.1 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 597.07% in 2021 and slumped 53.44% in 2024, its largest moves.
• Tracing KBLB's Liabilities and Shareholders Equity over 5 years: stood at $3.0 million in 2021, then soared by 51.26% to $4.6 million in 2022, then retreated by 29.27% to $3.2 million in 2023, then slumped by 53.44% to $1.5 million in 2024, then surged by 70.43% to $2.6 million in 2025.
• Business Quant data shows KBLB's Liabilities and Shareholders Equity at $2.6 million in Q4 2025, $2.4 million in Q3 2025, and $1.6 million in Q2 2025.